Cite
Genetic Risk Variants Interacting With MIR137: Effects On Cognition, Brain Structure And Brain Function In Patients And Healthy Participants.
MLA
Donohoe, Gary, et al. “Genetic Risk Variants Interacting With MIR137: Effects On Cognition, Brain Structure And Brain Function In Patients And Healthy Participants.” European Neuropsychopharmacology, vol. 29, Jan. 2019, pp. S729–30. EBSCOhost, https://doi.org/10.1016/j.euroneuro.2017.06.051.
APA
Donohoe, G., Cosgrove, D., Motherills, D., Harold, D., Kelly, S., Holleran, L., Holland, J., Wellcome Trust CCC, Anney, R., Richards, A., Owen, M., O’Donovan, M., Gill, M., Corvin, A., & Morris, D. (2019). Genetic Risk Variants Interacting With MIR137: Effects On Cognition, Brain Structure And Brain Function In Patients And Healthy Participants. European Neuropsychopharmacology, 29, S729–S730. https://doi.org/10.1016/j.euroneuro.2017.06.051
Chicago
Donohoe, Gary, Donna Cosgrove, David Motherills, Denise Harold, Sinead Kelly, Laurena Holleran, Jessica Holland, et al. 2019. “Genetic Risk Variants Interacting With MIR137: Effects On Cognition, Brain Structure And Brain Function In Patients And Healthy Participants.” European Neuropsychopharmacology 29 (January): S729–30. doi:10.1016/j.euroneuro.2017.06.051.